Our analysis of public datasets confirmed that high KLK8 expression correlates with poor patient outcomes in 10 out of 13 human cancer types examined, as described previously for pancreatic, endometrial, and breast cancers, as well as for clear cell renal cell carcinoma and urothelial bladder carcinoma57–62. This evidence concerns the gene KLK8 and breast cancer.